Form 4: GeneDx Holdings Corp. CFO Transactions

GeneDx Holdings Corp. CFO Kevin Feeley reports on stock transactions, including RSU vesting and sale to cover tax obligations.

Summary

• Kevin Feeley, Chief Financial Officer of GeneDx Holdings Corp., reported transactions on June 9, 2026.
• He acquired 2,462 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs) with no cost.
• Additionally, 1,266 shares were disposed of at a price of $53.77 to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, Feeley beneficially owns 36,486 shares of Class A Common Stock.
• He also holds RSUs representing contingent rights to 89,240 shares and options for 25,906 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details routine insider stock transactions related to compensation and tax obligations, without indicating significant buying or selling pressure.

Positives

• Vesting of 2,462 Restricted Stock Units (RSUs) indicates continued equity-based compensation for the CFO.
• The CFO's beneficial ownership of 36,486 shares of Class A Common Stock demonstrates a significant personal stake in the company.

Negatives

• The disposal of 1,266 shares to cover tax withholding obligations, while standard, represents a reduction in the CFO's direct holdings.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and are crucial for understanding executive compensation and potential insider sentiment regarding company stock.

Stakeholder Impact

• Shareholders: The transaction provides transparency into executive compensation and insider holdings, which can influence investor confidence.

Key Dates

Keywords

Form 4, SEC Filing, GeneDx Holdings Corp., Kevin Feeley, CFO, Stock Transaction, RSU Vesting, Class A Common Stock, Beneficial Ownership, Tax Withholding